MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Tamura, Yukihiro ^a,b   Higashi, Michiyo ^a   Kitamoto, Sho ^a   Yokoyama, Seiya ^a   Osako, Masahiko ^c   Horinouchi, Michiko ^c   Shimizu, Takeshi ^c   Tabata, Mineo ^c   Batra, Surinder K ^d   Goto, Masamichi ^a,e   Yonezawa, Suguru ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Ohsumi Kanoya Hospital   (Japan)

^c Kagoshima City Hospital   (Japan)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e National Sanatorium Hoshizuka Keiaien   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1G8; MONOCLONAL ANTIBODY 8G7; MONOCLONAL ANTIBODY DF3; MUCIN 1; MUCIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOOD VESSELS; CELL LINE, TUMOR; EARLY DETECTION OF CANCER; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCIN-1; MUCIN-4; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84869015889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049251     Document Type: Article

References (34)

1. Correa P, Piazuelo MB, Camargo MC, (2004) The future of gastric cancer prevention. Gastric Cancer 7: 9-16.
2. Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, et al. (2011) Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 14: 301-316.
3. Association JGC, (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14: 113-123.
4. Yonezawa S, Higashi M, Yamada N, Yokoyama S, Kitamoto S, et al. (2011) Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application. Pathol Int 61: 697-716.
5. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M, (2008) Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 8: 3329-3341.
6. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, et al. (1998) Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 4: 2605-2614.
7. Porchet N, Nguyen VC, Dufosse J, Audie JP, Guyonnet-Duperat V, et al. (1991) Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun 175: 414-422.
8. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA, (2003) Cell signaling through membrane mucins. Bioessays 25: 66-71.
9. Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, et al. (2012) MUC4: a novel prognostic factor of oral squamous cell carcinoma. International journal of cancer Journal international du cancer 130: 1768-1776.
10. Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, et al. (2004) MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39: 220-229.
11. Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, et al. (2006) MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clinical cancer research 12: 4257-4264.
12. Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, et al. (2005) MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol 58: 845-852.
13. Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, et al. (2007) MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung cancer 55: 195-203.
14. Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, et al. (2004) Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. J Histochem Cytochem 52: 253-261.
15. Zhang J, Perez A, Yasin M, Soto P, Rong M, et al. (2005) Presence of MUC4 in human milk and at the luminal surfaces of blood vessels. J Cell Physiol 204: 166-177.
16. JGC A, (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112.
17. Lauwers GY, Garneiro F, Graham DY, Curado MP, Franceschi S, et al. (2010) Tumours of the stomach, in WHO Classification of Tumours of the Digestive System, edited by Bosman FT, Carneiro F, Hruban RH, Theise ND, 4th Edition. International Agency for Research on Cancer, Lyon. 45-80.
18. Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, et al. (2008) Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer 99: 949-956.
19. Alos L, Lujan B, Castillo M, Nadal A, Carreras M, et al. (2005) Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 29: 806-813.
20. Handra-Luca A, Lamas G, Bertrand JC, Fouret P, (2005) MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 29: 881-889.
21. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, et al. (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18: 1295-1304.
22. Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, et al. (2006) Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 19: 1386-1394.
23. Nam KH, Noh TW, Chung SH, Lee SH, Lee MK, et al. (2011) Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. Thyroid 21: 745-750.
24. Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, et al. (2006) Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate 66: 421-429.
25. Baek SK, Woo JS, Kwon SY, Lee SH, Chae YS, et al. (2007) Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma. Laryngoscope 117: 911-916.
26. Shanmugam C, Jhala NC, Katkoori VR, Wan W, Meleth S, et al. (2010) Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer 116: 3577-3586.
27. Weed DT, Gomez-Fernandez C, Pacheco J, Ruiz J, Hamilton-Nelson K, et al. (2004) MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma. Head & neck 26: 353-364.
28. Weed DT, Gomez-Fernandez C, Yasin M, Hamilton-Nelson K, Rodriguez M, et al. (2004) MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes. The Laryngoscope 114: 1-32.
29. Kwon KY, Ro JY, Singhal N, Killen DE, Sienko A, et al. (2007) MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. Archives of pathology & laboratory medicine 131: 593-598.
30. Jeon JM, Lee HW, Park JY, Jung HR, Hwang I, et al. (2010) Expression of MUC1 and MUC4 and Its Prognostic Significance in Non-Small Cell Lung Carcinoma. The Korean Journal of Pathology 44: 397-403.
31. Westgaard A, Schjolberg AR, Cvancarova M, Eide TJ, Clausen OP, et al. (2009) Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology 54: 337-347.
32. Moniaux N, Nollet S, Porchet N, Degand P, Laine A, et al. (1999) Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 338 (Pt 2): 325-333.
33. Khorrami AM, Choudhury A, Andrianifahanana M, Varshney GC, Bhattacharyya SN, et al. (2002) Purification and characterization of a human pancreatic adenocarcinoma mucin. J Biochem 131: 21-29.
34. Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, et al. (2001) Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 7: 4033-4040.